Deflazacort

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

31 API Suppliers, 6 USDMF, 7 NDC API, 28 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

9 Drugs in Development

9 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

72 FDF Dossiers, 18 FDA Orange Book, 32 Europe, 22 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 18MG, TABLET;ORAL - 30MG, TABLET;ORAL - 36MG, TABLET;ORAL - 6MG, SUSPENSION;ORAL - 22.75MG/ML

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc, 5 SPI Pharma, 3 DKSH, 3 Faran Shimi Pharmaceutical, 3 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 3 Actylis, 1 Aeon Procare, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 BASF, 2 DFE Pharma, 1 Finar, 4 Gangwal Chemicals, 2 Ingredion Pharma Solutions, 15 Kerry, 1 Kima Chemical, 10 Microlex e.U, 1 Nanjing Bold Chemical, 3 Pluviaendo, 1 Prachin Chemical, 17 Roquette, 7 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 4 Sigachi Industries, 1 The Dow Chemical Company, 1 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

42 Fillers, Diluents & Binders, 14 Solubilizers, 13 Thickeners and Stabilizers, 12 Film Formers & Plasticizers, 11 Lubricants & Glidants, 11 Direct Compression, 9 Parenteral, 7 Coating Systems & Additives, 7 Co-Processed Excipients, 7 Taste Masking, 6 Rheology Modifiers, 6 Emulsifying Agents, 5 Chewable & Orodispersible Aids, 5 Granulation, 5 Topical, 4 Disintegrants & Superdisintegrants, 2 API Stability Enhancers, 2 Surfactant & Foaming Agents, 1 Controlled & Modified Release, 1 Soft Gelatin